D. Yordanov

Molecular Medicine · 2009

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

Whom D. Yordanov trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Hooper (in Molecular Medicine)

Who trusts D. Yordanov

  1. K. Poole (in Molecular Biology)

Papers from D. Yordanov's perspective

Ordered by how strongly the researchers D. Yordanov trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. (Clinical Microbiology and Infection)
  2. Emerging mechanisms of fluoroquinolone resistance. (Emerging Infectious Diseases)
  3. qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States (Antimicrobial Agents and Chemotherapy)
  4. The worldwide emergence of plasmid-mediated quinolone resistance. (Lancet. Infectious Diseases (Print))
  5. Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae (Antimicrobial Agents and Chemotherapy)
  6. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies (Critical Care)
  7. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
  8. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. (Lancet. Infectious Diseases (Print))
  9. Efflux-mediated multiresistance in Gram-negative bacteria. (Clinical Microbiology and Infection)
  10. Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in France (Antimicrobial Agents and Chemotherapy)

Their papers